Literature DB >> 11461763

Syntheses and evaluation of halogenated cytisine derivatives and of bioisosteric thiocytisine as potent and selective nAChR ligands.

P Imming1, P Klaperski, M T Stubbs, G Seitz, D Gündisch.   

Abstract

We have developed one-step syntheses of halogenated derivatives of (-)-cytisine featuring a halogen substituent at positions 3, 5 or 3 and 5 of the 2-pyridone fragment, and prepared the novel bioisosteric thiocytisine by oxygen-sulphur exchange. The affinities of these pyridone-modified analogs of (-)-cytisine for (alpha 4)(2)(beta 2)(3) and alpha 7* nAChRs in rat forebrain membranes were determined by competition with (+/-)-[(3)H]epibatidine and [(3)H]MLA, respectively. The 3-halocytisines 7 possess subnanomolar affinities for (alpha 4)(2)(beta 2)(3) nAChRs, higher than those found for (-)-cytisine as well as for the 5-halocytisines 8 and 3,5-dihalocytisines 6. In contrast to the parent alkaloid the 3-halogenated species display much a higher affinity for the alpha 7* nAChR subtype. The most potent molecule was 3-bromocytisine (7b) with preferential selectivity (200-fold) for the (alpha 4)(2)(beta 2)(3) subtype [K(i)=10 pM (alpha 4 beta 2) and 2.0 nM (alpha 7*)]. Replacement of the lactam with a thiolactam pharmacophore to thiocytisine (12) resulted in a subnanomolar affinity for the (alpha 4)(2)(beta 2)(3) nAChR subtype (K(i)=0.832 nM), but in a drastic decrease of affinity for the alpha 7* subtype; thiocytisine (12) has a K(i) value of 4000 nM (alpha 7*), giving a selectivity of 4800-fold for the neuronal (alpha 4)(2)(beta 2)(3)-nAChR and thus displaying the best affinity-selectivity profile in the series under consideration.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11461763     DOI: 10.1016/s0223-5234(01)01222-3

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  10 in total

1.  The twin drug approach for novel nicotinic acetylcholine receptor ligands.

Authors:  Isabelle Tomassoli; Daniela Gündisch
Journal:  Bioorg Med Chem       Date:  2015-06-20       Impact factor: 3.641

2.  The 3,7-diazabicyclo[3.3.1]nonane scaffold for subtype selective nicotinic acetylcholine receptor (nAChR) ligands. Part 1: the influence of different hydrogen bond acceptor systems on alkyl and (hetero)aryl substituents.

Authors:  Christoph Eibl; Isabelle Tomassoli; Lenka Munoz; Clare Stokes; Roger L Papke; Daniela Gündisch
Journal:  Bioorg Med Chem       Date:  2013-10-05       Impact factor: 3.641

Review 3.  Nicotinic agonists, antagonists, and modulators from natural sources.

Authors:  John W Daly
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

4.  Pharmacokinetics of cytisine after single intravenous and oral administration in rabbits.

Authors:  Henri Astroug; Roumiana Simeonova; Lilia V Kassabova; Nikolay Danchev; Dobrin Svinarov
Journal:  Interdiscip Toxicol       Date:  2010-03-29

5.  In vivo effects of 3-iodocytisine: pharmacological and genetic analysis of hypothermia and evaluation of chronic treatment on nicotinic binding sites.

Authors:  C A Zambrano; M J Marks; B K Cassels; R B Maccioni
Journal:  Neuropharmacology       Date:  2009-05-28       Impact factor: 5.250

6.  The 3,7-diazabicyclo[3.3.1]nonane scaffold for subtype selective nicotinic acetylcholine receptor ligands. Part 2: carboxamide derivatives with different spacer motifs.

Authors:  Christoph Eibl; Lenka Munoz; Isabelle Tomassoli; Clare Stokes; Roger L Papke; Daniela Gündisch
Journal:  Bioorg Med Chem       Date:  2013-10-05       Impact factor: 3.641

7.  Cytisine-based nicotinic partial agonists as novel antidepressant compounds.

Authors:  Yann S Mineur; Christoph Eibl; Grace Young; Christopher Kochevar; Roger L Papke; Daniela Gündisch; Marina R Picciotto
Journal:  J Pharmacol Exp Ther       Date:  2009-01-22       Impact factor: 4.030

8.  Structural characterization of binding mode of smoking cessation drugs to nicotinic acetylcholine receptors through study of ligand complexes with acetylcholine-binding protein.

Authors:  Prakash Rucktooa; Claire A Haseler; René van Elk; August B Smit; Timothy Gallagher; Titia K Sixma
Journal:  J Biol Chem       Date:  2012-05-02       Impact factor: 5.157

9.  N-Methyl-2-thio-cytisine.

Authors:  Anita M Owczarzak; Anna K Przybył; Maciej Kubicki
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-07-07

10.  Fluorescence activation mechanism and imaging of drug permeation with new sensors for smoking-cessation ligands.

Authors:  Aaron L Nichols; Zack Blumenfeld; Chengcheng Fan; Laura Luebbert; Annet E M Blom; Bruce N Cohen; Jonathan S Marvin; Philip M Borden; Charlene H Kim; Anand K Muthusamy; Amol V Shivange; Hailey J Knox; Hugo Rego Campello; Jonathan H Wang; Dennis A Dougherty; Loren L Looger; Timothy Gallagher; Douglas C Rees; Henry A Lester
Journal:  Elife       Date:  2022-01-04       Impact factor: 8.140

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.